Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation - PubMed (original) (raw)
Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation
Amy K McNally et al. Am J Pathol. 2002 Feb.
Abstract
An in vitro system of interleukin (IL)-4-induced human monocyte-derived macrophage fusion was used to investigate the cell/substrate adhesive mechanisms that support multinucleated foreign body giant cell (FBGC) formation. Monocytes were cultured for 3 days and IL-4 was added to induce macrophage fusion and FBGC formation by day 7. Functionally defined anti-integrin antibodies demonstrated that initial monocyte adhesion is mediated by beta2 integrins, whereas during the induction of macrophage fusion by IL-4, an additional dependence on beta1 integrins is acquired. The combination of anti-beta1 plus anti-beta2 was most effective, reducing macrophage/FBGC adhesion to 10% of controls. Consistent with integrin-mediated signaling, the tyrosine kinase inhibitor genistein and the phosphatidylinositol-3-kinase inhibitors wortmannin and LY294002 also attenuated macrophage/FBGC adhesion. Confocal microscopic analysis revealed that beta2 integrins are present on monocytes after initial adhesion and are strongly expressed on fusing macrophages, particularly in peripheral cell areas, and on FBGCs. In contrast, beta1 integrins are not detected on monocytes but begin to appear during macrophage development and are strongly expressed on fusing macrophages and FBGCs. For the first time, these results demonstrate the IL-4-induced acquisition of cooperation between beta1 and beta2 integrins in the cell/substrate adhesive interactions that are required for multinucleated FBGC formation.
Figures
Figure 1.
The effects of EDTA or EGTA and various inhibitors of nonintegrin receptors on initial monocyte adhesion (A) and macrophage/FBGC adhesion (B). Freshly isolated monocytes or macrophages/FBGCs (day 3 to day 7) were treated with the indicated inhibitors as described in Materials and Methods. Results are expressed as the percent adhesion of untreated control cells, n = 3 monocyte donors. From left to right: EDTA, 10 mmol/L; EGTA, 10 mmol/L; heparin, 2 μmol/L; dextran sulfate, 25 μg/ml; lipopolysaccharide (LPS), 50 μg/ml; chondroitin sulfate A (CS-A), 1 mg/ml; chondroitin sulfate B (CS-B), 1 mg/ml.
Figure 2.
Effects of soluble fibronectin or its proteolytic fragments on initial monocyte adhesion (A) and macrophage/FBGC adhesion (B). Freshly isolated monocytes or macrophages/FBGCs (day 3 to day 7) were treated with 0.05 mg/ml (solid bars), 0.1 mg/ml (shaded bars), or 0.25 mg/ml (open bars) of purified plasma fibronectin (FN), the 120-kd FN fragment, the 40-kd FN fragment, or human serum albumin as described in Materials and Methods. Results are expressed as the percent adhesion of untreated control cells, n = 3 monocyte donors.
Figure 3.
The effects of anti-integrin antibodies on initial monocyte adhesion (A) or macrophage/FBGC adhesion (B). Freshly isolated monocytes or macrophages/FBGCs (day 3 to day 7) were treated with 50 μg/ml each of the indicated anti-integrin antibodies (b1, β1; b2, β2; b3, β3; aM, αM) individually or in various combinations or with nonspecific control IgGs as described in Materials and Methods. Results are expressed as the percent adhesion of untreated control cells, n = 3 monocyte donors.
Figure 4.
The effects of inhibitors of integrin-mediated cell signaling. Increasing concentrations of the tyrosine kinase inhibitor genistein (A) or the phosphatidylinositol-3-kinase inhibitors LY294002 (B) and wortmannin (C) were added during the induction of macrophage fusion/FBGC formation (day 3 to day 7) as described in Materials and Methods. Results are expressed as the percent adhesion of untreated control cells, n = 3 monocyte donors.
Figure 5.
Expression of integrins on monocytes or monocyte-derived macrophages. Integrin expression was analyzed on monocytes after initial adhesion after 1.5 hours (A, B, and C) or on day 3 of culture (D, E, and F). Permeabilized cells were stained with mouse monoclonal anti-integrin detecting antibodies (Table 1) ▶ and anti-mouse IgG conjugated to Cy-5. A and D, β1 integrin; B and E, β2 integrin; and C and F, β3 integrin. Representative images are of single 2-μm slices at the cell/substrate interface. Scale bars, 50 μm.
Figure 6.
Expression of integrins on fusing macrophages/FBGCs. A, β1 integrin; B, β2 integrin; and C, β3 integrin. Cells were fixed and permeabilized on day 7 after the induction of macrophage fusion by IL-4. Fusing macrophages/FBGCs were then stained with mouse monoclonal anti-integrin detecting antibodies (Table 1) ▶ followed by a mixture of anti-mouse IgG conjugated to Cy-5 (green, integrins), rhodamine phalloidin (red, F-actin), and YO-YO-1 (blue, nuclei). Representative micrographs are shown of merged Z-series images. Scale bars, 50 μm.
Similar articles
- alpha subunit partners to beta1 and beta2 integrins during IL-4-induced foreign body giant cell formation.
McNally AK, Macewan SR, Anderson JM. McNally AK, et al. J Biomed Mater Res A. 2007 Sep 1;82(3):568-74. doi: 10.1002/jbm.a.31161. J Biomed Mater Res A. 2007. PMID: 17311314 - Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties.
McNally AK, Anderson JM. McNally AK, et al. J Biomed Mater Res A. 2015 Apr;103(4):1380-90. doi: 10.1002/jbm.a.35280. Epub 2014 Jul 26. J Biomed Mater Res A. 2015. PMID: 25045023 Free PMC article. - Foreign body-type multinucleated giant cell formation is potently induced by alpha-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022.
McNally AK, Anderson JM. McNally AK, et al. Am J Pathol. 2003 Sep;163(3):1147-56. doi: 10.1016/s0002-9440(10)63474-8. Am J Pathol. 2003. PMID: 12937156 Free PMC article. - Macrophage fusion and multinucleated giant cells of inflammation.
McNally AK, Anderson JM. McNally AK, et al. Adv Exp Med Biol. 2011;713:97-111. doi: 10.1007/978-94-007-0763-4_7. Adv Exp Med Biol. 2011. PMID: 21432016 Review. - Monocyte-Macrophage Lineage Cell Fusion.
Kloc M, Subuddhi A, Uosef A, Kubiak JZ, Ghobrial RM. Kloc M, et al. Int J Mol Sci. 2022 Jun 12;23(12):6553. doi: 10.3390/ijms23126553. Int J Mol Sci. 2022. PMID: 35742997 Free PMC article. Review.
Cited by
- Cellular and microenvironmental cues that promote macrophage fusion and foreign body response.
Stewart CL, Hook AL, Zelzer M, Marlow M, Piccinini AM. Stewart CL, et al. Front Immunol. 2024 Jul 5;15:1411872. doi: 10.3389/fimmu.2024.1411872. eCollection 2024. Front Immunol. 2024. PMID: 39034997 Free PMC article. - In vivo label-free tissue histology through a microstructured imaging window.
Conci C, Sironi L, Jacchetti E, Panzeri D, Inverso D, Martínez Vázquez R, Osellame R, Collini M, Cerullo G, Chirico G, Raimondi MT. Conci C, et al. APL Bioeng. 2024 Jan 9;8(1):016102. doi: 10.1063/5.0165411. eCollection 2024 Mar. APL Bioeng. 2024. PMID: 38222895 Free PMC article. - Aggressive giant cell lesion of mandible-confusing to common: true neoplasm versus reactive lesion.
Arumugam SD, Kanniyappan B, Giri U, Muthanandam S. Arumugam SD, et al. BMJ Case Rep. 2023 May 4;16(5):e253499. doi: 10.1136/bcr-2022-253499. BMJ Case Rep. 2023. PMID: 37142281 - Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses.
Dooling LJ, Andrechak JC, Hayes BH, Kadu S, Zhang W, Pan R, Vashisth M, Irianto J, Alvey CM, Ma L, Discher DE. Dooling LJ, et al. Nat Biomed Eng. 2023 Sep;7(9):1081-1096. doi: 10.1038/s41551-023-01031-3. Epub 2023 Apr 24. Nat Biomed Eng. 2023. PMID: 37095318 Free PMC article. - Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling.
Poulis N, Martin M, Hoerstrup SP, Emmert MY, Fioretta ES. Poulis N, et al. Front Cardiovasc Med. 2022 Sep 13;9:952178. doi: 10.3389/fcvm.2022.952178. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36176991 Free PMC article. Review.
References
- Murch AR, Grounds MD, Marshall CA: Direct evidence that inflammatory multinucleate giant cells form by fusion. J Pathol 1980, 137:177-180 - PubMed
- Chambers TJ, Spector WG: Inflammatory giant cells. Immunobiology 1982, 161:2283-2289 - PubMed
- Anderson JM: Inflammatory response to implants. Am Soc Artif Intern Organs 1988, 11:101-107 - PubMed
- Zhao Q, Topham NS, Anderson JM, Hiltner A, Lodoen G, Payet R: Foreign body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking. J Biomed Mater Res 1991, 25:177-183 - PubMed
- Wiggins MJ, Wilkoff B, Anderson JM, Hiltner A: Biodegradation of polyether polyurethane inner insulation in bipolar pacemaker leads. J Biomed Mater Res 2001, 58:302-307 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources